Safety and Pharmacodynamic Study of ABT-436 in Major Depressive Disorder
Status:
Completed
Trial end date:
2011-09-01
Target enrollment:
Participant gender:
Summary
This is a multiple-dose study to assess the safety and pharmacology of ABT-436 in physically
healthy subjects with mild to moderate depressive symptoms who are not taking any
antidepressant medication. Efficacy for treatment of depressive symptoms is not a goal of
this study.